On Medindia find the complete list of Central Nervous System Agents drugs with their available forms and strength. More information is available on each drug including their price list.

If the latest neurosteroid fails against Huntington's, it's going lower than that and the company's future is very much in doubt. Central nervous system drug development is definitely for the brave.

This is the second major pharma company to tap into Autifony’s ion channel drug discovery platform after ... track record” of bringing new CNS therapies to market, alluding to the company ...

A broad range of nanomedicines is being developed to improve drug delivery for CNS disorders. The structure of the blood-brain barrier (BBB), the presence of efflux pumps and the expression of ...

Schmidt compared J-Brain Cargo to a rocket that can bring satellites (biologic drugs) into the CNS orbit, where they can exert their therapeutic effect. JCR has been focusing on fusing therapeutic ...

Central Nervous System drug discovery is making a comeback, but what strategies and tactics can expedite your efforts as a medicinal chemist working on CNS programs? Join Craig Lindsley of the ...

Central Nervous System (CNS) therapies have significantly progressed in the last decade, propelled by emerging treatment modalities including gene therapies. Neurological indications remain amongst ...

The site is expected to become operational in 2029. "Sanofi gains exclusivity rights to Ventyx’s CNS-penetrant drug in $27m ...

In the case of drugs developed for central nervous system (CNS) conditions such as Alzheimer disease and Parkinson disease, getting through the blood–brain barrier (BBB) is a major hurdle.

This not only makes eradication of the virus very difficult but also increases the risk of viral mutation, leading to drug resistance and treatment failure. One of these sites is the CNS.